<code id='DECB75495A'></code><style id='DECB75495A'></style>
    • <acronym id='DECB75495A'></acronym>
      <center id='DECB75495A'><center id='DECB75495A'><tfoot id='DECB75495A'></tfoot></center><abbr id='DECB75495A'><dir id='DECB75495A'><tfoot id='DECB75495A'></tfoot><noframes id='DECB75495A'>

    • <optgroup id='DECB75495A'><strike id='DECB75495A'><sup id='DECB75495A'></sup></strike><code id='DECB75495A'></code></optgroup>
        1. <b id='DECB75495A'><label id='DECB75495A'><select id='DECB75495A'><dt id='DECB75495A'><span id='DECB75495A'></span></dt></select></label></b><u id='DECB75495A'></u>
          <i id='DECB75495A'><strike id='DECB75495A'><tt id='DECB75495A'><pre id='DECB75495A'></pre></tt></strike></i>

          Home / hotspot / hotspot

          hotspot


          hotspot

          author:entertainment    Page View:72
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In